Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
will be Professor Ulrik Wisløff (NTNU). Professor Dorthe Stensvold (NTNU) and Postdoctor Atefe R. Tari (NTNU) will serve as co-supervisors. Your immediate leader will be the Head of Department. About the
-
. This postdoctoral focuses on developing a new paradigm for the circular manufacturing of heterogeneous photonic integrated circuits. While heterogeneous integration has emerged as the leading approach for combining
-
-time postdoctoral researcher to join an ambitious research program dedicated to the discovery and development of mixed-anion thermoelectric materials. The project is funded by the University of Caen
-
of postdoctoral research fellow, research fellow, research assistant and resident - University of Oslo (uio.no) (https://www.uio.no/english/about/regulations/personnel/academic/regulations-employment-conditions
-
paid time off. To access this tool and learn more about the total value of your benefits, please click on the following link: https://resources.uta.edu/hr/services/records/compensation-tools.php CBC
-
related technologies. Keywords: Particle accelerator, Beam-driven plasma, Low-energy beamline, High-intensity accelerator For information about our laboratory, please refer to the following link: https
-
physical, chemical, materials, life and medical sciences as well as physics of dense plasmas, warm dense matter, and laboratory astrophysics. The ELI Beamlines Facility employs over 350 researchers
-
online application process? Please read the FAQ or contact us via [email protected] . Where to apply Website https://academicpositions.com/ad/ghent-university/2026/postdoctoral-researcher-… Requirements
-
astrophysics, nuclear structure, heavy-ion physics and physics of the quark-gluon plasma, perturbative QCD, quantum few- and many-body systems, quantum computing, and machine learning and artificial intelligence
-
recruiting a Postdoctoral Researcher to the NCN OPUS 30 project entitled „New 1,3,4-thiadiazole derivatives in glioblastoma therapy - assessment of the activity and revealing the mechanism of action" (2025/59